Health Care Resource Utilization (HCRU) Before and After the Initiation of Cannabidiol Among Those With Refractory Epilepsies

5/20/2025
2:00 PM - 3:00 PM Eastern

Join Jazz Pharmaceuticals on May 20 for this important presentation on Health Care Resource Utilization (HCRU) Before and After the Initiation of Cannabidiol Among Commercial and Medicaid Patients with Lennox-Gastaut Syndrome (LGS), Dravet Syndrome (DS), Tuberous Sclerosis Complex (TSC) and other Refractory Epilepsies.  Presentation objectives:

• Discuss HCRU and Medical costs before and after Epidiolex® (cannabidiol) initiation
• Review anti-seizure medicine and anxiolytic medication use before and after Epidiolex® (cannabidiol) initiation

Presenter

• Michael Faithe, Director, Payer Value & Outcomes, Jazz Pharmaceuticals

Click here to Join the Webinar

Click on the icon next to the date(s) to add to your calendar:

5/20/2025

Click here to setup an email reminder for this event